NCT06676475View on ClinicalTrials.gov

Comparison Between Botox and Magnesium Sulfate Effect in Treatment of Myofascial Pain Trigger Points Within the Masseter Muscle

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

August 31, 2025

Conditions
Myofacial PainTrigger Points, Myofascial
Interventions
DRUG

MgSO4

2ml MgSo4 (Magnesium sulfate sterile ampoule 10 ml, 100 mg/ml = 0.41 mMol/ml. Egyptian Int. Pharmaceutical Industries Co., Egypt).

DRUG

BOTOX-A

2ml of BTX

DRUG

Saline (NaCl 0,9 %) (placebo)

2 ml of saline

Trial Locations (1)

Unknown

Misr university for science and technology, Giza

All Listed Sponsors
lead

Misr University for Science and Technology

OTHER

NCT06676475 - Comparison Between Botox and Magnesium Sulfate Effect in Treatment of Myofascial Pain Trigger Points Within the Masseter Muscle | Biotech Hunter | Biotech Hunter